课题基金 / 基金详情

Multimodal Artificial Intelligence to Predict Glaucomatous Progression and Surgical Intervention

Multimodal Artificial Intelligence to Predict Glaucomatous Progression and Surgical Intervention
多模态人工智能预测青光眼进展和手术干预
批准号:
10677890
负责人:
Sally Liu Baxter
金额:
$41.04万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2026-08-31

项目摘要

项目成果

Sally Liu Baxter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The overall objective of this proposal, “Multimodal Artificial Intelligence to Predict Glaucomatous Progression and Surgical Intervention”, is to use multimodal artificial intelligence (AI) and deep learning strategies to predict which glaucoma patients will need glaucoma surgery and which are likely to have progressive visual field loss in the future. This study is designed to leverage longstanding well characterized clinical and research cohorts of glaucoma patients and its validated decision support AI infrastructure to predict which glaucoma patients will progress and which will need surgery. The proposal includes the following two Specific Aims. Aim 1 will use baseline electronic health records (EHR), optic nerve head (ONH) optical coherence tomography (OCT) imaging, visual field (VF) data, intraocular pressure (IOP) and central corneal thickness (CCT) in a multimodal DL model to predict the likelihood of surgical intervention for glaucoma. Aim 2 will use baseline EHR, ONH OCT imaging, VF data, IOP and CCT in a multimodal DL model to predict the likelihood of fast glaucomatous visual field progression. To address these aims, existing data from glaucoma patients 1) enrolled in the National Eye Institute funded Diagnostic Innovations in Glaucoma Study (DIGS 1995-present) and African Descent and Glaucoma Evaluation Study (ADAGES 2009-2021), and 2) managed at the UCSD Viterbi Family Department of Ophthalmology will be used in the AI model development and testing. We will also leverage UCSD's existing cloud-based AI pipeline to build a glaucoma-specific platform to train, test and in the future, update the deep learning models developed. In the future, this infrastructure can be used to support randomized clinical trial testing of AI guided glaucoma management and enable real-time decision support for clinicians.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PAGE-G: Precision Approach combining Genes and Environment in Glaucoma
Bridge2AI: Salutogenesis Data Generation Project
  • 批准号:
    10858583
  • 项目类别:
  • 资助金额:
    $84.18万
  • 财政年份:
    2022
  • 负责人:
    Sally Liu Baxter
  • 依托单位:
Bridge2AI: Salutogenesis Data Generation Project
  • 批准号:
    10471118
  • 项目类别:
  • 资助金额:
    $783.8万
  • 财政年份:
    2022
  • 负责人:
    Sally Liu Baxter
  • 依托单位:
Short-Term Research training In Vision and Eye health (STRIVE)
海外基金